ICC International Cannabis (KNHBF) Stock Price, News & Analysis

Company Overview

ICC International Cannabis (OTCMKTS:KNHBF) is a diversified cannabis and hemp-focused company that specializes in the cultivation, processing, and distribution of cannabinoid-based products. Through its network of strategic investments and operating subsidiaries, ICC International Cannabis develops proprietary production techniques to supply a range of therapeutic, wellness, and lifestyle applications. The company’s operations encompass both indoor and greenhouse cultivation facilities designed to meet stringent quality and regulatory standards across multiple jurisdictions.

The company’s product portfolio includes dried flower, concentrated oils, tinctures, edibles, and topical formulations derived from both cannabis and hemp. ICC International Cannabis employs advanced extraction and refinement processes to isolate cannabinoids such as CBD and CBG, with an emphasis on creating consistent, pharmaceutical-grade ingredients. In addition to in-house manufacturing, the company provides contract cultivation and white-label services to licensed producers and brands seeking to enter emerging markets.

Originally founded under a different name and rebranded following a series of targeted acquisitions, ICC International Cannabis has expanded its footprint beyond North America into key European markets. The company has established partnerships with research institutes to explore novel cannabinoid applications, including dermatological and nutraceutical innovations. This strategic growth has been supported by capital raises and joint ventures that enhance the company’s capacity and geographic reach.

ICC International Cannabis is guided by a management team with deep experience in agricultural science, pharmaceutical manufacturing, and international commerce. Senior leadership oversees compliance with evolving regulatory landscapes, while a board of advisors offers expertise in clinical research and global distribution. Looking ahead, the company aims to scale its production capabilities and pursue additional licensing opportunities in Latin America, Asia-Pacific, and other regions embracing cannabis reform.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 5,000 shs
• Average Volume: 671,882 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KNHBF Stock Analysis - Frequently Asked Questions

How do I buy shares of ICC International Cannabis?

Shares of KNHBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:KNHBF
• CIK: N/A
• Web: www.kanehbosmbiotech.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A